ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Alvogen Issues Voluntary Nationwide Recall of Clindamycin Injection Due to a Potential for a Lack of
americanpharmaceuticalreview
June 22, 2017Alvogen is voluntarily recalling seven lots of Clindamycin Injection?USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction
Pharma Sources Insight January 2025
